Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 7, 1999, Pages 1343-1350

  Cvekl, Ales ^a,c   Kashanchi, Fatah ^b,d   Brady, John N ^b   Piatigorsky, Joram ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTALLIN; RETINOBLASTOMA PROTEIN; TATA BINDING PROTEIN;

ARTICLE; CELL DIVISION; EYE DEVELOPMENT; GENE EXPRESSION; GROWTH REGULATION; LENS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; CHROMATOGRAPHY, AFFINITY; CRYSTALLINS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; EYE PROTEINS; GLUTATHIONE TRANSFERASE; HOMEODOMAIN PROTEINS; LENS, CRYSTALLINE; MOLECULAR SEQUENCE DATA; PAIRED BOX TRANSCRIPTION FACTORS; PLASMIDS; PRECIPITIN TESTS; RABBITS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TATA BOX; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS;

EID: 0033014232     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Glaser T, Walton DS, Cai J, Epstein JA, Jepeal L, Maas RL. PAX6 gene mutations in aniridia. In: Wiggs J, ed. Molecular Genetics of Ocular Disease. New York: Wiley; 1995:55-81.
2. Cvekl A, Piatigorsky J. Lens development and crystallin gene expression: many roles for Pax-6. Bioessays. 1996;18:621-630.
3. Macdonald R, Wilson SW. Pax proteins and eye development. Curr Opin Neurobiol. 1996;6:49-56.
4. Callaerts P, Halder G, Gehring WJ. Pax-6 in development and evolution. Annu Rev Neurosci. 1997;20:483-532.
5. Hanson IM, Fletcher JM, Jordan T, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peter's anomaly. Nat Genet. 1994;6:168-173.
6. Mirzayans F, Pearce WG, MacDonald IM, Walter MA. Mutation of the PAX gene in patients with autosomal dominant keratitis. Am J Hum Genet. 1995;57:539-548.
7. Azuma N, Nishina S, Yanagisawa H, Okuyama T, Yamada M. PAX6 missense mutation in isolated foveal hypoplasia. Nat Genet. 1996; 13:141-142.
8. Hill RE, Favor J, Hogan BLM, et al. Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature. 1991;354:522-525.
9. Glaser T, Jepeal L, Edwards JG, Young SR, Favor J, Maas RL. PAX6 gene dosage effects in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet. 1994;7:463-471.
10. Schedl A, Ross A, Lee M, et al. Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell. 1996;86:71-82.
11. Sheng G, Thouvenot E, Schmucker D, Wilson DS, Desplan C. Direct regulation of rhodopsin 1 by Pax-6/eyeless in Drosophila: evidence for a conserved function in photoreceptors. Genes Dev. 1997;11:1122-1131.
12. Li, HS, Yang JM, Jacobson RD, Pasko D, Sundin O. Pax-6 is first expressed in a region of ectoderm anterior to the early neural plate: implications for stepwise determination of the lens. Dev Biol. 1994;162:181-194.
13. Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development. 1991;113:1435-1449.
14. Zhang H, Catron KM, Abate-Shen C. A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. Proc Natl Acad Sci USA. 1996;93:1764-1769.
15. Um M, Li C, Manley JL. The transcriptional repressor Even-skipped interacts directly with TATA-binding protein. Mol Cell Biol. 1995; 15:5007-5016.
16. Burley SK, Roeder RG. Biochemistry and structural biology of transcription factor HD (TFIID). Annu Rev Biochem. 1996;65: 769-799.
17. Zawel L, Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu Rev Biochem. 1995;64: 533-561.
18. Skapek SX, Qian YW, Lee EYHP. The retinoblastoma protein: more than meets the eyes. Prog Retinal Eye Res. 1997;16:591-6626.
19. Wiggan O, Taniguchi-Sidle A, Hamel PA. Interaction of the pRB-family proteins with factors containing paired-like homeodomains. Oncogene. 1998;16:227-236.
20. Cvekl A, Sax CM, Bresnick EH, Piatigorsky J. A complex array of positive and negative elements regulates the chicken αA-crystallin gene: involvement of Pax-6, USF, CREB and/or CREM, and AP-1 proteins. Mol Cell Biol. 1994;14:7363-7376.
21. Cvekl A, Kashanchi F, Sax CM, Brady JN, Piatigorsky J. Transcriptional regulation of the mouse αA-crystallin gene: activation dependent on a cyclic AMP-responsive element (DE1/CRE) and a Pax-6-binding site. Mol Cell Biol. 1995;15:653-660.
22. Cvekl A, Sax CM, Li X, McDermott JB, Piatigorsky J. Pax-6 and lens-specific transcription of the chicken δ1-crystallin gene. Proc Natl Acad Sci USA. 1995;92:4681-4685.
23. Richardson J, Cvekl A, Wistow G. Pax-6 is essential for lens-specific expression of ζ-crystallin. Proc Natl Acad Sci USA. 1995;92:4676-4680.
24. Sharon-Friling R, Richardson J, Sperbeck S, et al. Lens-specific recruitment of ζ-crystallin through Pax6, Nrl-Maf, and brain suppressor sites. Mol Cell Biol. 1998;18:2067-2076.
25. Gopal-Srivastava R, Cvekl A, Piatigorsky J. Pax-6 and αB-crystallin/small heat shock protein gene regulation in the murine lens: interaction with the lens-specific regions, LSR1 and LSR2. J Biol Chem. 1996;271:23029-23036.
26. Duncan M, Haynes JI, Cvekl A, Piatigorsky J. Dual roles for Pax-6: a transcriptional repressor of lens fiber-cell specific β-crystallin genes. Mol Cell Biol. 1998;18:5579-5586.
27. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by RB-deficiency in the developing mouse lens. Nature. 1994;371:72-74.
28. Maandag ECR, van der Valk M, Vlaar M, et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBOJ. 1994;13:4260-4268.
29. Williams, BO, Schmitt EM, Remington L, et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBOJ. 1994;13:4251-4259.
30. Fromm L, Shawlot W, Gunning K, Butel JS, Overbeek PA. The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lens of transgenic mice. Mol Cell Biol. 1994;14:6743-6754.
31. Pan H, Griep AE. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 1994;8:1285-1299.
32. Czemy T, Schaffner G, Busslinger M. DNA sequence recognition structure of the paired domain and its binding site. Genes Dev. 1993;7:2048-2061.
33. Tanaka M, Herr W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell. 1990;60:375-386.
34. Chow KNB, Dean DC. Domains: A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol. 1996; 16: 4862-4868.
35. Tamami M, Lindholm PF, Brady JN. The retinoblastoma gene product (Rb) induces binding of a conformationally inactive nuclear factor-κB. J Biol Chem. 1996;271:24551-24556.
36. Wilson DS, Sheng G, Jun S, Desplan C. Conservation and diversification in homeodomain-DNA interactions: a comparative genetic analysis. Proc Natl Acad Sci USA. 1996;93:6886-6891.
37. Pognonec P, Kato H, Sumimoto H, Kretzschmar M, Roeder RG. A quick procedure for purification of functional recombinant proteins over-expressed in E. coli. Nucleic Acids Res. 1991;19: 6650.
38. Carriere C, Plaza S, Martin P, et al. Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina. Mol Cell Biol. 1993;13:7257-7266.
39. Davis JA, Reed RR. Role of Olf-1 and Pax-6 transcription factors in neurodevelopment. J Neurosci. 1996;16:5082-5094.
40. Nakajima N, Horikoshi M, Roeder RG. Factors involved in specific transcription by mammalian RNA polymerase: purification, genetic specificity and TATA-box promoter interactions of TFIID. Mol Cell Biol. 1998;8:4028-4040.
41. Kashanchi F, Piras G, Radonovich MF, et al. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature. 1994;367: 295-299.
42. Lai JS, Herr W. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci USA. 1992;89:6958-6962.
43. Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R, Shenk T. Two domains of p53 interact with the TATA-binding protein, and the Adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol. 1995;15: 227-234.
44. Hagemeier C, Bannister AJ, Cook A, Kouzarides T. The activation domain of transcription factor PU. 1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA. 1993;90:1580-1584.
45. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992;258:424-429.
46. Taya Y. RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci. 1997;22:14-17.
47. Rampalli AM, Chauthaiwale VM, Gao CY, Zelenka PS. pRb and p107 regulate E2F activity during lens fiber cell differentiation. Oncogene. 1998;16:399-408.
48. Yamada T, Nakamura T, Westphal H, Russell P. Synthesis of α-crystallin by a cell line derived from the lens of a transgenic animal. Curr Eye Res. 1989;9:31-37.
49. Buratowski S, Zhou H. Transcription factor IID mutants defective for interactions with transcription factor IIA. Science. 1992;255: 1130-1132.
50. Lee WS, Kao CC, Bryant GO, Liu X, Berk AJ. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell. 1991;67:365-376.
51. Kerr LD, Ransone LJ, Wamsley P, et al Association between protooncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature. 1993;365:412-419.
52. Melcher K, Johnston SA. GAL4 interacts with TATA-binding protein and coactivators. Mol Cell Biol. 1995;15:2839-2848.
53. Emili A, Greenbelt J, Ingles CJ. Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol. 1994;14:1582-1593.
54. Mason PB, Lis JT Cooperative and competitive interactions at the hsp70 promoter. J Biol Chem. 1997;272:33227-33233.
55. Singh S, Tang HK, Lee JY, Saunders GF. Truncation mutations in the transactivation region of PAX6 result in dominant-negative mutants. J Biol Chem. 1998;273:21531-21541.
56. Sax CM, Cvekl A, Kantorow M, et al. Lens-specific activity of the mouse αA-crystallin promoter in the absence of a TATA box: functional and protein binding analysis of the mouse αA-crystallin PE1 region. Nucleic Acids Res. 1995;23:442-451.
57. Haynes JI, Gopal-Srivastava R, Piatigorsky J. αB-crystallin TATA sequence mutations: lens-preference for the proximal TATA box and the distal TATA-like sequence in transgenic mice. Biochem Biophys Res Commun. 1997;241:407-413.
58. Dorfler P, Busslinger M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J. 1996;15:1971-1982.
59. Lechner MS, Dressier GR. Mapping of Pax-2 transcription activation domains. J Biol Chem. 1996;271:21088-21093.
60. Lieberman PM, Berk AJ. A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation. Genes Dev. 1994;8:995-1006.
61. Burley SK, Roeder RG. TATA box mimicry by TFIID: autoinhibition of Pol II transcription. Cell. 1998;94:551-553.
62. Jacks T, Weinberg RA. The expanding role of cell cycle regulators. Science. 1998;280:1035-1036.
63. Maulbecker CC, Gruss P. The oncogenic potential of Pax genes. EMBO J. 1993;12:2361-2367.